159 related articles for article (PubMed ID: 22790134)
1. Recovery of kidney function by rituximab-based therapy in a patient with Waldenström's macroglobulinemia-related nephropathy presenting cast nephropathy and interstitial lymphocytic infiltration.
Miwa M; Sakao Y; Ishigaki S; Ono M; Fujikura T; Yasuda H; Suzuki H; Kato A; Nagata Y; Shigeno K; Nakamura S; Ohnishi K; Fujigaki Y
Intern Med; 2012; 51(13):1725-30. PubMed ID: 22790134
[TBL] [Abstract][Full Text] [Related]
2. Cast nephropathy in a case of Waldenström's macroglobulinemia.
Isaac J; Herrera GA
Nephron; 2002 Jul; 91(3):512-5. PubMed ID: 12119489
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of cryoglobulinemic glomerulonephritis derived from Waldenström's macroglobulinemia by rituximab-CHOP and tandem high-dose chemotherapy with autologous peripheral blood stem cell transplantation.
Kawano N; Ikeda N; Yoshida S; Sugio Y; Yamashita K; Uezono S; Hayashi T; Hara S; Makino S; Shimoda K; Ueda A
Int J Hematol; 2010 Sep; 92(2):391-7. PubMed ID: 20686877
[TBL] [Abstract][Full Text] [Related]
4. Endobronchial involvement with Waldenström's macroglobulinemia.
Sakai I; Shiroguchi T; Kanegae H; Matumoto I
Intern Med; 1992 Sep; 31(9):1098-101. PubMed ID: 1421716
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of diffuse large B-cell lymphoma following Waldenström's macroglobulinemia with CHOP chemotherapy followed by combination therapy of CHOP with rituximab.
Uchino K; Sameshima H; Miyamoto T; Iino T; Kato K; Henzan H; Aoki K; Nagafuji K; Gondo H; Harada M
Intern Med; 2004 Feb; 43(2):131-4. PubMed ID: 15005256
[TBL] [Abstract][Full Text] [Related]
6. Pentostatin, cyclophosphamide and rituximab is a safe and effective treatment in patients with Waldenström's macroglobulinemia.
Herth I; Hensel M; Rieger M; Horstmann K; Hiddemann W; Dreyling M; Koniczek S; Witzens-Harig M; Ho AD
Leuk Lymphoma; 2015 Jan; 56(1):97-102. PubMed ID: 24724778
[TBL] [Abstract][Full Text] [Related]
7. [Complete response achieved after rituximab plus CHOP therapy in a patient with rapidly progressing Waldenstrom's macroglobulinemia].
Ise M; Sakai C; Kumagai K
Rinsho Ketsueki; 2009 Jan; 50(1):34-8. PubMed ID: 19225227
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin M 'Flare' after rituximab-associated acute tubular necrosis in Waldenström's macroglobulinemia.
Izzedine H; Bourry E; Amrouche L; Brocheriou I; Uzunov M; Capron F; Leblond V; Deray G
Int J Hematol; 2009 Mar; 89(2):218-222. PubMed ID: 19156501
[TBL] [Abstract][Full Text] [Related]
9. Pentostatin/cyclophosphamide with or without rituximab: an effective regimen for patients with Waldenstrom's macroglobulinemia/lymphoplasmacytic lymphoma.
Hensel M; Villalobos M; Kornacker M; Krasniqi F; Ho AD
Clin Lymphoma Myeloma; 2005 Sep; 6(2):131-5. PubMed ID: 16231851
[TBL] [Abstract][Full Text] [Related]
10. Waldenström macroglobulinaemia and intestinal lymphangiectasia.
Cooke RE; Kalnins RM; Ho WK
Br J Haematol; 2014 Nov; 167(3):292. PubMed ID: 25039993
[No Abstract] [Full Text] [Related]
11. Cast nephropathy: an extremely rare renal presentation of Waldenström's macroglobulinaemia.
Santos T; Machado S; Sousa V; Campos M
BMJ Case Rep; 2015 Oct; 2015():. PubMed ID: 26446315
[TBL] [Abstract][Full Text] [Related]
12. Waldenström's macroglobulinemia and nephrotic syndrome with membranous nephropathy.
Lee B; Smith RS; Tanphaichitr N; Novak R; Robertson S; Haller NA
Scand J Urol Nephrol; 2011 Dec; 45(6):473-7. PubMed ID: 21612326
[TBL] [Abstract][Full Text] [Related]
13. Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemia.
Treon SP; Gertz MA; Dimopoulos M; Anagnostopoulos A; Blade J; Branagan AR; Garcia-Sanz R; Johnson S; Kimby E; Leblond V; Fermand JP; Maloney DG; Merlini G; Morel P; Morra E; Nichols G; Ocio EM; Owen R; Stone MJ
Blood; 2006 May; 107(9):3442-6. PubMed ID: 16410453
[TBL] [Abstract][Full Text] [Related]
14. Comparative outcomes following CP-R, CVP-R, and CHOP-R in Waldenström's macroglobulinemia.
Ioakimidis L; Patterson CJ; Hunter ZR; Soumerai JD; Manning RJ; Turnbull B; Sheehy P; Treon SP
Clin Lymphoma Myeloma; 2009 Mar; 9(1):62-6. PubMed ID: 19362976
[TBL] [Abstract][Full Text] [Related]
15. Renal involvement in Waldenström's macroglobulinemia: case report and review of literature.
Salviani C; Guido G; Serriello I; Giannakakis K; Rocca AR
Ren Fail; 2014 Feb; 36(1):114-8. PubMed ID: 24059636
[TBL] [Abstract][Full Text] [Related]
16. Myelopathy from Waldenström's macroglobulinemia: improvement after Rituximab therapy.
Liberato B; Riethmuller A; Comenzo RL; Lis E; Raizer JJ
J Neurooncol; 2003 Jun; 63(2):207-11. PubMed ID: 12825826
[TBL] [Abstract][Full Text] [Related]
17. [Bing-Neel syndrome revealing Waldenström's macroglobulinemia].
Drouet T; Behin A; Psimaras D; Choquet S; Guillevin R; Hoang Xuan K
Rev Neurol (Paris); 2010 Jan; 166(1):66-75. PubMed ID: 19403149
[TBL] [Abstract][Full Text] [Related]
18. A case with acute renal failure complicated by Waldenström's macroglobulinemia and cryoglobulinemia.
Yonemura K; Suzuki T; Sano K; Fujigaki Y; Ikegaya N; Hishida A
Ren Fail; 2000; 22(4):511-5. PubMed ID: 10901188
[TBL] [Abstract][Full Text] [Related]
19. Rituximab, Cyclophosphamide, Dexamethasone (RCD) regimen induces cure in WSU-WM xenograft model and a partial remission in previously treated Waldenstrom's macroglobulinemia patient.
Mohammad RM; Aboukameel A; Nabha S; Ibrahim D; Al-Katib A
J Drug Target; 2002 Aug; 10(5):405-10. PubMed ID: 12442811
[TBL] [Abstract][Full Text] [Related]
20. Immunobullous dermatosis associated with Waldenström macroglobulinaemia treated with rituximab.
Chattopadhyay M; Rytina E; Dada M; Bhogal BS; Groves R; Handfield-Jones S
Clin Exp Dermatol; 2013 Dec; 38(8):866-9. PubMed ID: 23782150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
